{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Tucson&page=35&state=Arizona", "query": { "state": "Arizona", "city": "Tucson", "page": 35 }, "page_size": 10 }, "pagination": { "page": 35, "page_size": 10, "total_count": 1091, "total_pages": 110, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Tucson&page=36&state=Arizona&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Tucson&page=34&state=Arizona&page_size=10" }, "source": "local", "last_synced_at": "2026-10-20T13:37:26.698Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06657144", "title": "A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Advanced Solid Tumor", "Metastatic Solid Tumor" ], "interventions": [ { "name": "5 Fluorouracil", "type": "DRUG" }, { "name": "CHS-114", "type": "DRUG" }, { "name": "Cisplatin", "type": "DRUG" }, { "name": "Toripalimab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Coherus Oncology, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 154, "start_date": "2025-04-01", "completion_date": "2028-01", "has_results": false, "last_update_posted_date": "2026-07-15", "last_synced_at": "2026-10-20T13:37:26.698Z", "location_count": 20, "location_summary": "Tucson, Arizona • Duarte, California • Aurora, Colorado + 16 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Duarte", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "New Orleans", "state": "Louisiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT06657144" }, { "nct_id": "NCT05121051", "title": "Testing the Effect of the Broccoli Seed and Sprout Extract, Avmacol ES, on the Cancer Causing Substances of Tobacco in Heavy Smokers", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Cigarette Smoking-Related Carcinoma" ], "interventions": [ { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Broccoli Sprout/Broccoli Seed Extract Supplement", "type": "DIETARY_SUPPLEMENT" }, { "name": "Placebo Administration", "type": "DRUG" }, { "name": "Questionnaire Administration", "type": "OTHER" } ], "intervention_types": [ "PROCEDURE", "DIETARY_SUPPLEMENT", "DRUG", "OTHER" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 135, "start_date": "2022-09-21", "completion_date": "2027-12-31", "has_results": false, "last_update_posted_date": "2026-07-14", "last_synced_at": "2026-10-13T20:35:36.387Z", "location_count": 3, "location_summary": "Tucson, Arizona • Washington D.C., District of Columbia • Buffalo, New York", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Buffalo", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT05121051" }, { "nct_id": "NCT05921214", "title": "The Effect of Semantic Support on Word Learning", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Language Development Disorders" ], "interventions": [ { "name": "VAULT Phase 5", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Arizona", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": "4 Years", "sex": "ALL", "summary": "2 Years to 4 Years" }, "enrollment_count": 32, "start_date": "2025-06-10", "completion_date": "2026-12-01", "has_results": false, "last_update_posted_date": "2026-07-13", "last_synced_at": "2026-08-10T11:49:02.920Z", "location_count": 1, "location_summary": "Tucson, Arizona", "locations": [ { "city": "Tucson", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT05921214" }, { "nct_id": "NCT03972657", "title": "A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Clear Cell Renal Cell Carcinoma (ccRCC)", "Metastatic Castration-Resistant Prostate Cancer (mCRPC)" ], "interventions": [ { "name": "Cemiplimab", "type": "DRUG" }, { "name": "REGN5678", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Regeneron Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 345, "start_date": "2019-08-12", "completion_date": "2027-11-15", "has_results": false, "last_update_posted_date": "2026-07-09", "last_synced_at": "2026-10-16T22:16:54.327Z", "location_count": 24, "location_summary": "Gilbert, Arizona • Phoenix, Arizona • Tucson, Arizona + 17 more", "locations": [ { "city": "Gilbert", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Santa Monica", "state": "California" }, { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT03972657" }, { "nct_id": "NCT06920043", "title": "A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Metabolic Dysfunction-Associated Steatohepatitis", "Non-alcoholic Fatty Liver Disease" ], "interventions": [ { "name": "Efimosfermin", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 42, "start_date": "2025-04-09", "completion_date": "2028-07-10", "has_results": false, "last_update_posted_date": "2026-07-08", "last_synced_at": "2026-10-13T22:31:51.633Z", "location_count": 28, "location_summary": "Chandler, Arizona • Mesa, Arizona • Tucson, Arizona + 22 more", "locations": [ { "city": "Chandler", "state": "Arizona" }, { "city": "Mesa", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Fresno", "state": "California" }, { "city": "Lancaster", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06920043" }, { "nct_id": "NCT06836609", "title": "A Study to Evaluate ALN-CIDEB in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease or With Metabolic Dysfunction-Associated Steatohepatitis (MASLD/MASH)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Metabolic Dysfunction-Associated Steatohepatitis", "Metabolic Dysfunction-Associated Steatotic Liver Disease" ], "interventions": [ { "name": "ALN-CIDEB", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Regeneron Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 132, "start_date": "2025-04-28", "completion_date": "2027-05-15", "has_results": false, "last_update_posted_date": "2026-07-08", "last_synced_at": "2026-10-08T00:20:16.064Z", "location_count": 2, "location_summary": "Chandler, Arizona • Tucson, Arizona", "locations": [ { "city": "Chandler", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT06836609" }, { "nct_id": "NCT05548283", "title": "Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Cystic Fibrosis", "Cystic Fibrosis Pulmonary Exacerbation" ], "interventions": [ { "name": "Aminoglycoside", "type": "DRUG" }, { "name": "Beta-lactam antibiotic", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Chris Goss", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": null, "sex": "ALL", "summary": "6 Years and older" }, "enrollment_count": 730, "start_date": "2023-04-23", "completion_date": "2027-05-31", "has_results": false, "last_update_posted_date": "2026-07-08", "last_synced_at": "2026-07-29T07:44:36.830Z", "location_count": 59, "location_summary": "Birmingham, Alabama • Tucson, Arizona • La Jolla, California + 49 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "La Jolla", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Orange", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05548283" }, { "nct_id": "NCT07687745", "title": "Breathing for Two: Inspiratory Muscle Strength Training for Supporting Healthy Blood Pressure in Pregnancy", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Blood Pressure Measurement in Pregnancy", "Hypertension Disorders in Pregnancy", "Inspiratory Strength Training (IST)", "Pregnancy" ], "interventions": [ { "name": "Exercise at 15% PI max", "type": "OTHER" }, { "name": "Exercise at 50% PI max", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Arizona", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "FEMALE", "summary": "18 Years to 55 Years · Female only" }, "enrollment_count": 80, "start_date": "2026-06-08", "completion_date": "2027-09-30", "has_results": false, "last_update_posted_date": "2026-07-07", "last_synced_at": "2026-08-03T06:36:45.666Z", "location_count": 1, "location_summary": "Tucson, Arizona", "locations": [ { "city": "Tucson", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT07687745" }, { "nct_id": "NCT06562543", "title": "A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Colorectal Cancer" ], "interventions": [ { "name": "Fruquintinib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Takeda", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 78, "start_date": "2025-01-14", "completion_date": "2027-10-04", "has_results": false, "last_update_posted_date": "2026-07-07", "last_synced_at": "2026-10-13T21:03:41.492Z", "location_count": 44, "location_summary": "Birmingham, Alabama • Chandler, Arizona • Tucson, Arizona + 34 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Chandler", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "La Jolla", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06562543" }, { "nct_id": "NCT07464860", "title": "Feasibility of Breathwork Intervention With Older Adults After Knee Surgery", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Breathing Exercises", "Breathing Techniques", "Cortisol", "Hypothalamic Pituitary Adrenal", "Postoperative Anxiety", "Postoperative Depression", "Postoperative Pain", "Quality of Recovery (QoR-15)", "Relaxation", "Relaxation Therapy", "Stress Physiological", "Stress Physiology", "Stress Psychological", "Surgical Stress Response" ], "interventions": [ { "name": "A 5-minute Asynchronous Breathwork Intervention", "type": "BEHAVIORAL" }, { "name": "A 5-minute Asynchronous Card Game Video", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Arizona", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "65 Years", "maximum_age": null, "sex": "ALL", "summary": "65 Years and older" }, "enrollment_count": 32, "start_date": "2026-07-01", "completion_date": "2026-11-30", "has_results": false, "last_update_posted_date": "2026-07-06", "last_synced_at": "2026-08-02T08:25:48.118Z", "location_count": 1, "location_summary": "Tucson, Arizona", "locations": [ { "city": "Tucson", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT07464860" } ] }